Surmodics, Inc. (DELISTED) (SRDX:DL)
42.98
0.00 (0.00%)
USD |
NASDAQ |
Nov 28, 16:00
Surmodics Total Assets (Quarterly): 169.82M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 648.44M |
| Atossa Therapeutics, Inc. | 58.01M |
| Abeona Therapeutics, Inc. | 231.10M |
| Kiora Pharmaceuticals, Inc. | 29.86M |
| Intellia Therapeutics, Inc. | 925.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.51M |
| Shareholders Equity (Quarterly) | 111.31M |
| Debt to Equity Ratio | 0.2927 |
| Current Ratio | 3.909 |
| Net Debt Paydown Yield | 0.05% |